All articles tagged: Alzheimer's disease (G30)
![]()
HealthDay
13 June at 04.08 PM
Lifestyle Intervention Can Improve Cognition, Function in Early Alzheimer DiseaseFor patients with mild cognitive impairment (MCI) or early dementia due to Alzheimer disease (AD), comprehensive lifestyle changes may improve cognition and function, according to a study published online June 7 in Alzheimer's Research & Therapy.Dean Ornish, M.D., from Preventive Medicine Research Institute in Sausalito, Californi |
![]()
Evalytics
13 May at 08.55 PM
Genes known to increase the risk of Alzheimer’s may actually be an inherited form of the disorder, researchers sayA new study suggests that the APOE4 gene variant increases Alzheimer's risk more than previously thought. Individuals with two copies of the APOE4 gene are estimated to have a 60-70% chance of developing Alzheimer's by age 85. Understanding genetic risk factors can help identify those most vulnerable and inform personalized preventive measures. |
![]()
Evalytics
29 April at 06.31 PM
Workings of working memory detailedCedars-Sinai researchers identified neurons in the brain responsible for coordinating focus and short-term memory, crucial for tasks like recalling a phone number. These neurons, influenced by brain waves, aid in retaining information in working memory. The study, published in Nature, sheds light on brain processes crucial for understanding and treating conditions like Alzheimer's disease and ADHD |
![]()
Evalytics
29 April at 06.23 PM
AI and Gut-Brain Axis: Unlocking New Avenues in Alzheimer’s Disease TreatmentRecent research highlights the link between the gut microbiome and neurological disorders like Alzheimer’s. Advancements in AI are aiding in the exploration of this connection, offering potential breakthroughs in treatment. This article explores how AI is used to analyze gut-brain interactions, suggesting novel avenues for therapeutic approaches in Alzheimer’s disease. |
![]()
Evalytics
19 March at 06.25 AM
Scientists take on 'moonshot' project mapping the human brain in hopes of fighting diseaseThe Allen Institute, founded by Paul Allen in 2003, embarked on an ambitious mission to map the 86 billion neurons of the human brain. This endeavor aims to decode the intricate workings of the brain and provide insights into various neurological diseases. |
![]()
Evalytics
11 March at 01.14 AM
FDA will take a deeper look into the safety and effectiveness of Lilly experimental Alzheimer's drugThe FDA is conducting further safety and effectiveness assessments of Eli Lilly's experimental Alzheimer's drug. This move follows concerns raised by its advisory panel regarding the drug's efficacy and side effects. The FDA's review aims to provide more clarity on the potential risks and benefits of the medication. |
![]()
Evalytics
05 March at 06.03 AM
Metformin's Potential Beyond Diabetes: Exploring Diverse Health BenefitsMetformin, a frontline treatment for type 2 diabetes, has long been a pharmaceutical mainstay, with over 91 million prescriptions in 2021 alone. However, recent evidence suggests that metformin's efficacy extends beyond diabetes management, encompassing various conditions such as cancer, obesity, liver disease, cardiovascular issues, neurodegenerative disorders, and renal diseases. As research exp |
![]()
Evalytics
19 February at 03.11 PM
New study confirms double the risk of dementia after mouth herpes simplex virusA study suggests a possible link between mouth herpes simplex virus and dementia. Researchers found higher levels of the virus in the brains of people with Alzheimer's disease. This association raises questions about the role of viral infections in neurodegenerative conditions. |
![]()
Evalytics
14 February at 07.19 PM
Researchers 3D-print functional human brain tissueUW-Madison scientists created 3D-printed brain tissue mimicking normal function, aiding research on disorders like Alzheimer's. They horizontally layered neurons in a soft gel, enabling communication and network formation resembling human brains, offering a precise and accessible technique for studying brain conditions and drug testing. |
![]()
HealthDay
31 January at 05.41 PM
Biogen Is Dropping Controversial Alzheimer's Drug AduhelmBiogen, maker of the Alzheimer's medicine Aduhelm, announced Wednesday that it would "discontinue the development and commercialization" of the controversial drug.Biogen will return the rights to Aduhelm to Neurimmune, the private firm that invented it, the company said in a <a href="https://in |
![]()
HealthDay
26 January at 10.04 PM
Monoclonal Antibodies Provide Small Benefits in Alzheimer DiseaseMonoclonal antibodies targeting amyloid provide small benefits on cognitive and functional scales, which do not meet the minimal clinically important difference, according to a review published in the January/February issue of the Annals of Family Medicine.Mark H. Ebell, M.D., from the University of Georgia in Athens, and colleagues con |
![]()
HealthDay
19 January at 04.55 PM
Study IDs Proportion of Dementia Cases Attributable to Known Risk FactorsKnown risk factors account for a considerable proportion of Alzheimer disease and related dementia (ADRD) cases, with unequal distribution across race and ethnic groups, according to a study published online Jan. 17 in Neurology.Using data from the Multiethnic Cohort Study participants, Song-Yi Park, Ph.D., from the University of Hawaii |
![]()
Evalytics
15 January at 04.41 PM
Differences in cerebrospinal fluid of Alzheimer's patients suggests possibility of variantsResearchers identified five distinct subtypes of Alzheimer's disease, each with unique cerebrospinal fluid protein profiles and genetic markers, suggesting the need for tailored treatments for each subtype. |
![]()
HealthDay
05 January at 04.59 AM
Racial/Ethnic Minorities Underrepresented in Alzheimer Neuroimaging ResearchRacial and ethnic minority groups are underrepresented in Alzheimer disease neuroimaging literature, according to a study published online July 25 in Communications Medicine.Aaron C. Lim, Ph.D., from the Keck School of Medicine of USC in Alhambra, California, and colleagues identified median race/ethnicity composition of Alzheimer disea |
![]()
HealthDay
08 December at 04.38 PM
Light Therapy Aids Psychobehavioral Symptoms With Alzheimer DiseaseLight therapy is associated with significant improvement in sleep and psychobehavioral symptoms in patients with Alzheimer disease, according to a review published online Dec. 6 in PLOS ONE.Lili Zang, from Weifang Medical University in China, and colleagues conducted a systematic literature review to identify studies evaluating the |
![]()
HealthDay
07 December at 04.43 PM
Transcranial Direct Current Stimulation Beneficial in Alzheimer DiseaseFor patients with Alzheimer disease (AD), active transcranial direct current stimulation (tDCS) may improve cognitive function, according to a study published online Dec. 5 in General Psychiatry.Xingxing Li, from the Ningbo Kangning Hospital & Affiliated Mental Health Centre at Ningbo University in China, and colleagues examined th |
![]()
Evalytics
27 November at 06.34 PM
A type of belly fat may be linked to increased risk of developing Alzheimer'sRecent research suggests that visceral fat, fat around the organs, could heighten the risk of Alzheimer's disease. This risk is present regardless of overall body weight and is linked to early brain changes related to Alzheimer's, emphasizing the importance of managing this type of fat. |
![]()
HealthDay
22 November at 10.37 PM
Whole Grain Consumption Linked to Slower Global Cognitive DeclineHigher consumption of whole grains is associated with a slower rate of global cognitive decline, according to a study published online Nov. 22 in Neurology.Xiaoran Liu, Ph.D., from Rush University Medical Center in Chicago, and colleagues examined the association of whole-grain consumption with longitudinal change in global cognition |
![]()
Medical xPress
30 June at 07.40 AM
Decision to offer sedation for often-painful IUD insertion is 'groundbreaking,' health experts sayIntrauterine devices (IUDs) are a highly effective and long-lasting form of birth control placed in the uterus. Research shows that many people who get IUDs experience moderate to intense pain during the insertion. But it wasn't until recently that providers began to acknowledge this and do something about it. |
![]()
HealthDay
27 June at 03.19 PM
Immunoglobulin Replacement Therapy Beneficial for Blood CancersImmunoglobulin replacement therapy (IgRT) is associated with reductions in hypogammaglobulinemia, infections, severe infections, and associated antimicrobial use among real-world patients with chronic lymphocytic leukemia (CLL) or non-Hodgkin lymphoma (NHL), according to a study published online June 21 in Blood Advances.Jacob D. Soum |
Medpage Today
26 June at 04.59 PM
When Was the Last Time You Really Talked With Your Patient?My 10 o'clock patient's name is Maria*. Her chart has three "health maintenance" flags that are bright red, indicating that she is more than 3 years overdue for a mammogram, more than 6 years overdue for a Pap smear, and has... |
Medpage Today
23 June at 09.21 PM
Novel Triple-Hormone Agonist Boosts Beta-Cell Function in T2DORLANDO -- An investigational triple-hormone receptor agonist improved metabolic profiles of people with obesity with or without type 2 diabetes, an exploratory biomarker analysis of a phase II trial found. After 36 weeks... |
Medpage Today
22 June at 06.00 PM
Fenofibrate Slows Diabetic Retinopathy ProgressionORLANDO -- The cholesterol drug fenofibrate reduced progression of early eye disease among diabetes patients, the LENS trial showed. The fibrate reduced progression of early diabetic retinopathy or maculopathy by a relative... |
Medpage Today
22 June at 06.00 PM
Preventing Surgical-Site Infections; Drugs Go Head to Head for Ischemic StrokeTTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech University Health Sciences Center... |
![]()
Medical xPress
22 June at 05.20 PM
Lawsuit could challenge trust in Ozempic and other popular weight loss drugsThe manufacturers of the most popular weight loss drugs are being challenged in court. |
![]()
HealthDay
21 June at 03.38 PM
Overall Prevalence of Being Up-to-Date With Lung Cancer Screening Is LowThe overall prevalence of up-to-date (UTD) lung cancer screening (LCS) was low in 2022, with prevalence increasing with age and number of comorbidities, according to a study published online June 10 in JAMA Internal Medicine.Priti Bandi, Ph.D., from the American Cancer Society in Atlanta, and colleagues estimated the contemporary preval |
Medpage Today
13 June at 06.56 PM
Upping Immunotherapy Activity; A Win for Lung Screening; Looming Drug Price Break?Finding a way to dissociate the activity of effector T cells from regulatory T cells could make immune checkpoint inhibitors more effective in the 60% of melanoma patients who do not benefit or develop resistance to the drugs... |
Medpage Today
08 June at 04.00 PM
Here Are the Top Supreme Court Health Cases to WatchBy early July, the Supreme Court will release its most controversial rulings for the 2023-2024 term. The Court's 6-3 conservative supermajority has already overturned Roe v. Wade, sharply limited affirmative action, expanded... |